Over 380 clinicians and practitioners signed a letter, requesting the DEA to issue a revised proposed rule to regulate the prescribing of controlled substances through telehealth as soon as possible to ensure adequate time for patients to continue existing care.
To read a full copy of the stakeholder letter, please click here.
Loading...
Reload document 
Open in new tab